title: Combining retinoic acid and oral arsenic may be potentially the first-line therapy for non-high-risk acute promyelocytic leukemia.
authors.affiliation: Department of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China;; Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
authors.forename: Lin
authors.initials: L
authors.lastname: Fu
authors.affiliation: Department of Biomedical Engineering, Chinese PLA General Hospital, Beijing 100853, China.
authors.forename: Jinlong
authors.initials: J
authors.lastname: Shi
authors.affiliation: Department of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China.
authors.forename: Jia
authors.initials: J
authors.lastname: Liu
authors.affiliation: Department of Hematology, Chinese PLA General Hospital, Beijing 100853, China.
authors.forename: Anqi
authors.initials: A
authors.lastname: Liu
authors.affiliation: Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China.
authors.forename: Kailin
authors.initials: K
authors.lastname: Xu
authors.affiliation: Department of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China.
authors.forename: Xiaoyan
authors.initials: X
authors.lastname: Ke